2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol has been researched along with palmitic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fako, VE; Liu, JY; Pflug, B; Wu, X; Zhang, JT | 1 |
1 other study(ies) available for 2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol and palmitic acid
Article | Year |
---|---|
Repositioning proton pump inhibitors as anticancer drugs by targeting the thioesterase domain of human fatty acid synthase.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Repositioning; Fatty Acid Synthases; Humans; Hydrogen-Ion Concentration; Lansoprazole; Palmitic Acid; Palmitoyl-CoA Hydrolase; Protein Structure, Tertiary; Proton Pump Inhibitors | 2015 |